Peregrine-Asset-Advisers

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-05
Total Holdings
161
Total Value
267319568
Accession Number
0001941040-25-000259
Form Type
13F-HR
Manager Name
Peregrine-Asset-Advisers
Data Enrichment
84% identified
136 identified25 unidentified

Holdings

161 positions • $267.3M total value
Manager:
Search and click to pin securities to the top
Page 9 of 9
CytomX Therapeutics, Inc.
Shares:10.0K
Value:$6.4K
% of Portfolio:0.0% ($6.4K/$267.3M)